z-logo
open-access-imgOpen Access
Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Author(s) -
Lianfang Shen,
Xiaoyan Jin,
Xumeng Wang,
Laizhen Tou,
Jian Huang
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000745
Subject(s) - fulvestrant , tamoxifen , cancer research , endocrine system , cyclin dependent kinase , aromatase , breast cancer , histone deacetylase , cancer , medicine , targeted therapy , oncology , hormone , biology , histone , cell cycle , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here